Convergent evolution by cancer and viruses in evading the NKG2D immune response by Baugh, R, Khalique, H, Seymour, LW

Laterally stabilized complexes of DNA with linear reducible polycations: strategy for triggered intracellular activation of DNA delivery vectors by Oupický, D, Parker, AL, Seymour, LW

Melittin enables efficient vesicular escape and enhanced nuclear access of nonviral gene delivery vectors by Ogris, M, Carlisle, RC, Bettinger, T, Seymour, LW

Attenuation of the hypoxia inducible factor pathway after oncolytic adenovirus infection coincides with decreased vessel perfusion by Yousaf, I, Kaeppler, J, Frost, S, Seymour, LW, Jacobus, EJ

Adenovirus hexon protein enhances nuclear delivery and increases transgene expression of polyethylenimine/plasmid DNA vectors by Carlisle, RC, Bettinger, T, Ogris, M, Hale, S, Mautner, V, Seymour, LW

Combining oncolytic adenovirus with radiation – a paradigm for the future of radiosensitization by O'Cathail, S, Pokrovska, TD, Maughan, TS, Fisher, KD, Seymour, LW, Hawkins, MA

A liposome-based cancer vaccine for a rapid and high-titre anti-ErbB-2 antibody response by Wallis, J, Katti, P, Martin, AM, Hills, T, Seymour, LW, Shenton, DP, Carlisle, RC

A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression by Fisher, KD, Ulbrich, K, Subr, V, Ward, CM, Mautner, V, Blakey, D, Seymour, LW

Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells by Dyer, A, Schoeps, B, Frost, S, Jakeman, P, Scott, EM, Freedman, J, Jacobus, EJ, Seymour, LW

Identification of FGF receptor-binding peptides for cancer gene therapy by Maruta, F, Parker, AL, Fisher, KD, Hallissey, MT, Ismail, T, Rowlands, DC, Chandler, LA, Kerr, DJ, Seymour, LW

Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin by Mulholland, PJ, Ferry, DR, Anderson, D, Hussain, SA, Young, AM, Cook, JE, Hodgkin, E, Seymour, LW, Kerr, DJ

Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells by Baugh, R, Khalique, H, Page, E, Lei-Rossmann, J, Wan, PK, Johanssen, T, Ebner, D, Ansorge, O, Seymour, LW

Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference by Dyer, A, Baugh, R, Chia, SL, Frost, S, Iris, Jacobus, EJ, Khalique, H, Pokrovska, TD, Scott, EM, Taverner, WK, Seymour, LW, Lei, J

External beam radiation therapy and enadenotucirev: Inhibition of the DDR and mechanisms of radiation-mediated virus increase by Pokrovska, TD, Jacobus, EJ, Puliyadi, R, Prevo, R, Frost, S, Dyer, A, Baugh, R, Rodriguez-Berriguete, G, Fisher, K, Giovanna, G, Herbert, K, Taverner, WK, Champion, BR, Higgins, G, Seymour, LW, Lei-Rossmann, J

Thermoresponsive polymer nanoparticles co-deliver RSV F trimers with a TLR-7/8 adjuvant by Francica, JR, Lynn, GM, Laga, R, Joyce, MG, Ruckwardt, TJ, Morabito, KM, Chen, M, Chaudhuri, R, Zhang, B, Sastry, M, Druz, A, Ko, K, Choe, M, Pechar, M, Georgiev, IS, Kueltzo, LA, Seymour, LW, Mascola, JR, Kwong, PD, Graham, BS, Seder, RA

Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens by Lynn, GM, Sedlik, C, Baharom, F, Zhu, Y, Ramirez-Valdez, RA, Coble, VL, Tobin, K, Nichols, SR, Itzkowitz, Y, Zaidi, N, Gammon, JM, Blobel, NJ, Denizeau, J, de la Rochere, P, Francica, BJ, Decker, B, Maciejewski, M, Cheung, J, Yamane, H, Smelkinson, MG, Francica, JR, Laga, R, Bernstock, JD, Seymour, LW, Drake, CG, Jewell, CM, Lantz, O, Piaggio, E, Ishizuka, AS, Seder, RA

Combining regulatory angiogenic gene therapy and virotherapy for the treatment of breast cancer by Bazan Peregrino, M

Other Authors: “…Seymour, LW…”